News

Following a successful 2025 kickoff in Illinois on March 25 and its third annual event in Massachusetts on June 4-5 featuring ...
Sage Healthspan is currently available exclusively for iOS on Apple’s App Store. Users are encouraged to begin by uploading pre-existing lab results to generate immediate health insights. For more ...
PALM BEACH, Fla., June 27, 2025 (GLOBE NEWSWIRE) -- In less than 24 hours after a meeting with the FDA, Ryan ElHosseiny, inventor and CEO of theranos, now calls on President Trump to pardon Elizabeth ...
As an innovative sleep product, the QuietLab stop snoring device is positioned as an ideal option for anyone seeking a ...
Nombre total de titres avec droits de vote: 37.435.640 (tous des actions ordinaires) Nombre total de droits de vote (= dénominateur): 37.435.640 (tous liés aux actions ordinaires) ...
The Russell 3000® Index is an equity index that tracks the performance of the largest 3,000 U.S. stocks by market capitalization. The Russell 2000® Index measures the performance of the 2,000 smallest ...
Total number of securities carrying voting rights: 37,435,640 (all ordinary shares) Total number of voting rights (= denominator): 37,435,640 (all relating to ordinary shares) ...
Vitalhub Corp. (TSX:VHI) (OTCQX:VHIBF) (the “Company” or “VitalHub”) announced today the voting results from its annual general meeting of shareholders held virtually on June 27, 2025. All director ...
Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) ("Titan" or the "Company") announced today that, pursuant to a securities purchase agreement (the “Purchase Agreement”) with Blue Harbour Asset Management L.
Hapbee Technologies Inc. (TSXV: HAPB), the digital wellness company behind the pioneering bio-streaming wearable platform, today announced the appointment of Ahsan Ashraf to its Board of Directors. Mr ...
High-resolution retinal imaging will be introduced by RetinalGenix as a value-added additional service at various locations in the near future. The integration of high-resolution imaging is expected ...
“All of the FDA 510K approvals can be searched online. This is a big day for theranos,” says ElHosseiny. “Our goal is to bring advanced diagnostic technology to the public in a safe, transparent way.